L500-0018 Screening compound: 1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide

L500-0018 Screening compound: 1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide
L500-0018 Screening compound: 1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L500-0018
1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L500-0018

Molecular Formula

C19H21N5O4S2 (C19 H21 N5 O4 S2)

Compound Name

1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide

IUPAC name

1-{[4-(5-methyl-124-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide

SMILES

Cc1nc(-c2csc(S(N(CC3)CCC3C(NCc3ncccc3)=O)(=O)=O)c2)no1

InChI

InChI=1S/C19H21N5O4S2/c1-13-22-18(23-28-13)15-10-17(29-12-15)30(26,27)24-8-5-14(6-9-24)19(25)21-11-16-4-2-3-7-20-16/h2-4,7,10,12,14H,5-6,8-9,11H2,1H3,(H,21,25)

InChI Key

IXNNIQIFRRQQMD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27458388

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.54

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.536

Distribution Coefficient, logD

1.536

Water Solubility, LogSw

-2.56

Polar Surface Area

97.829

Acid Dissociation Constant (pKa)

12.37

Base Dissociation Constant (pKb)

3.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

L500-0018 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L500-0018 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L500-0018?
Check Price and Availability of L500-0018, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L500-0018 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L500-0018
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L500-0018
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L500-0018 available by request